Yehuda Shapira
Hebrew University of Jerusalem
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yehuda Shapira.
Neuromuscular Disorders | 1994
Daphna Vilozni; Ephraim Bar-Yishay; Ilan Gur; Yehuda Shapira; Shirley Meyer; Simon Godfrey
The present study describes the use of simple video games for a 5-week regimen of respiratory muscle training in 15 patients with Duchenne muscular dystrophy (DMD) at various stages of the disease. The games were re-arranged to be operated and driven by the respiratory efforts of the patient and to incorporate accurate ventilation and time measurements. Improvement in respiratory performance was determined by maximum voluntary ventilation (MVV), maximal achieved ventilation (VEmax) during a progressive isocapnic hyperventilation manoeuvre (PIHV) and the PIHV duration. The actual training period was 23 +/- 4 days (mean +/- S.D.) at ventilatory effort of 46 +/- 6% MVV, for 10 +/- 3 min day-1. Patients with moderate impairment of lung function tests (LFT) showed an improvement in MVV, VEmax, and duration of PIHV of 12 +/- 7% (p < 0.02), 53 +/- 25% (p < 0.001) 57 +/- 21% (p < 0.01), respectively. Improvements correlated with actual training time and ventilation level, %MVV, but negatively correlated with years of immobilization and with the initial MVV. We conclude that computerized respiratory games may be applied for breathing exercises and may improve respiratory performance in recently immobilized children with DMD who have moderate impairment of LFT.
Pediatric Neurology | 1986
Rami Amit; Yehuda Shapira; Asher Blank; Memet Aker
Acute disseminated encephalomyelopathy and Guillain-Barré syndrome are both immunologically mediated para-infectious demyelinating disorders, the former affecting the central nervous system and the latter affecting the peripheral nervous system. The term encephalo-myelo-radiculo-neuropathy was introduced to describe cases in which major involvement of one system, most commonly the peripheral, was associated with mild involvement of the other. We present a case of acute severe demyelination simultaneously affecting both the central and the peripheral nervous systems in a 10-year-old female. This clinical picture combines acute disseminated encephalomyelopathy and Guillain-Barré syndrome, both of which are extremely severe.
Neuromuscular Disorders | 2004
Yoram Nevo; Miriam Kutai; Joseph Jossiphov; Amir Livne; Zvi Ne'eman; Talmon Arad; Ronit Popovitz-Biro; Jacob Atsmon; Yehuda Shapira; Dov Soffer
Macrophagic myofasciitis has been almost exclusively detected in adults only. We describe six children of Arab Moslem origin with this disorder. Three presented with hypotonia, developmental delay and seizures and were evaluated for a mitochondrial disorder. The other three children had hypotonia and predominantly motor delay. Five of the six families were consanguineous. A massive collection of macrophages was present in the fascia and adjacent epimysium in all biopsies. The macrophages were periodic-acid-Schiff positive and immunoreactive for CD68. One biopsy which was evaluated by electron microscopy and energy-dispersive X-ray microanalysis showed crystalline structures containing aluminum in macrophages. Two children with motor delay and hypotonia were treated with oral prednisone for 3 months with no clinical improvement. Genetic predisposition probably accounts for the variability in the prevalence of macrophagic myofasciitis in different populations. At least in childhood, there seems to be no connection between macrophagic myofasciitis as a pathological entity and the clinical symptoms and signs.
Developmental Medicine & Child Neurology | 2008
Yehuda Shapira; Gabriel Cividalli; Gershon Szabo; Raphael Roain; Alex Russell
A case of the myasthenic syndrome of Eaton‐Lambert is reported in a 10‐year‐old boy with leukemia. Neurological symptoms preceded the appearance of leukemia by more than a month: the child became easily fatigued and there was generalised weakness and wasting (mainly of proximal muscle groups), ophthalmoplegia and ptosis. There was no response to anticholinesterase agents.
The Journal of Pediatrics | 2003
Amir Livne; Yehuda Shapira; Russell C. Dale
Bradykinesia and rigidity developed in a 10-year-old girl during an episode of Sydenham chorea. These parkinsonian features improved over 6 months. Serum analysis demonstrated elevated anti-streptolysin-O and anti-basal ganglia antibodies. We suggest that autoimmune antibodies may cause remitting parkinsonian signs subsequent to streptococcal tonsillitis as part of the spectrum of poststreptococcal CNS disease.
Pediatric Neurology | 1993
Yehuda Shapira; Benjamin Glick; Shaul Harel; Jean Jacques Vattin; Alisa Gutman
A series of 9 infants, ranging in age from 3 months to 5 years (average: 2 years), suffered from idiopathic myopathic carnitine deficiency presenting as hypotonia and motor delay. Secondary carnitine deficiency was eliminated by appropriate tests. Muscle carnitine concentration ranged from 2.3-7.1 nmol/mg non-collagen protein (NCP; average: 4.87 nmol/mg NCP; normal: 22 +/- 6 nmol/mg NCP). Lipid accumulation in muscle was observed in 2 of 8 patients. Therapy with L-carnitine (100 mg/kg/day in most patients) was given with clinical and laboratory follow-up 6 months later. In 7 of 9 patients, muscle tone and motor function improved. Muscle carnitine concentration increased to a range of 2.7-23.4 nmol/mg (average: 12.27 nmol/mg). In some patients the muscle carnitine content multiplied by a factor of 3-4, but carnitine concentration reached the normal range in only 2 patients. Most infants with idiopathic carnitine deficiency did benefit from 6 months of therapy; however, in order to achieve full recovery the duration of therapy should probably continue for longer periods, with a dose of not less than 100 mg/kg/day.
Pediatric Neurology | 2002
Israel Matoth; Ilana Taustein; Barrie S Kay; Yehuda Shapira
The objective of the present study was to analyze the diagnostic indications that most often prompt the referral of children and adolescents in the outpatient clinical pediatric practice for electroencephalographic evaluation and to check its utility in these clinical conditions. The electroencephalographic records of 547 consecutive children and adolescents (5-16 years of age) referred to a single community laboratory for the evaluation of various neurologic disorders were prospectively read by a single blinded investigator. Common diagnostic indications included the following: clinical seizures (42%), attention-deficit-hyperactivity disorder (23%), headaches (10.4%), syncope (9.9%), and tic disorder (4.9%). Overall, 76% of records were normal. Slowing of electroencephalographic activity was noted in 1% (attention-deficit-hyperactivity disorder) to 26% (probable epilepsy), and epileptiform activity in 53% of the probable and 29% of the clinically possible epileptics. Epileptiform activity was rarely found in the nonepileptic patients. The results of the present study demonstrate that standard interictal electroencephalogram is being overused during evaluation of various neurologic disorders in children and adolescents, suggesting that its use should be reserved for supporting the diagnosis in those cases in which epilepsy is a reasonable clinical possibility.
American Journal of Medical Genetics Part A | 2003
Reeval Segel; Shira Silverstein; Israela Lerer; Esther Kahana; Rachel Meir; Michal Sagi; Nelly Zilber; Amos D. Korczyn; Yehuda Shapira; Zohar Argov; Dvorah Abeliovich
In a comprehensive epidemiological survey among Jews living in Israel, the average prevalence of myotonic dystrophy (DM) was 15.7/105 (1 case in 6,369) with intercommunity variations; the Ashkenazi Jews had the lowest rate, 5.7/105 (1 case in 17,544) as compared to the rate in the Sephardim/Oriental Jews 20/105 (1 case in 5,000) and the in the Yemenite Jews 47.3/105 (1 case in 2,114). The rate of unrelated DM‐sibships per 106 people of each community was used as an estimate of the transition rate from stable to unstable DMPK‐(CTG)n alleles assuming that each transition is a beginning of a new DM sibship. This study indicated that the difference in the incidence of DM is a result of higher mutation rate in the non‐Ashkenazi Jews (>50/106) as compared to the rate in the Ashkenazi Jews (16.3/106). The intragenic haplotype of the DM alleles was the same as that of the DM in many populations all over the world. However, two DM closely linked markers D19S207 and D19S112 were in linkage disequilibrium with the DM mutation in patients of Yemenite and Moroccan (the largest subgroup in the Sephardim Jews) extractions and not in the Ashkenazi patients. This observation indicated a common ancestral origin for the DM premutation in patients of the same ethnic origin. We concluded that the difference in the prevalence of DM among the Jewish communities is a consequence of founder premutations in the non‐Ashkenazi Jewish communities.
Clinical Pediatrics | 1974
Yehuda Shapira; Moshe Drucker; Alex Russell; R. Yarom
A one-month-old infant with chronic diarrhea, staphylococcus septicemia, otitis, mastoiditis, and malnutrition was treated by intravenous alimentation and multiple antibiotics. He developed an abscess at the site of an intrajugular indwelling plastic catheter, from which Candida was grown. He died suddenly with signs of endocarditis with embolization. Autopsy revealed disseminated candidiasis, endocarditis with large candidal vegetations on all valves, with multiple granulomata and microabscesses in the brain. The possible role of indwelling plastic catheters, mastoiditis, malnutrition, and antibiotics in the pathogenesis of disseminated candidiasis in infants is discussed. Candida endocarditis is very rare in children, and this case is the fourth to be reported in the literature.
Neuromuscular Disorders | 2015
Sharon Aharoni; Menachem Sadeh; Yehuda Shapira; Simon Edvardson; Muhannad Daana; Talia Dor-Wollman; Aviva Mimouni-Bloch; Ayelet Halevy; Rony Cohen; Liora Sagie; Zohar Argov; Malcolm Rabie; Ronen Spiegel; Ilana Chervinsky; Naama Orenstein; Andrew G. Engel; Yoram Nevo
The objective of the study was to evaluate the epidemiology of patients with congenital myasthenic syndrome (CMS) in Israel. Targeted mutation analysis was performed based on the clinical symptoms and electrophysiological findings for known CMS. Additional specific tests were performed in patients of Iranian and/or Iraqi Jewish origin. All medical records were reviewed and clinical data, genetic mutations and outcomes were recorded. Forty-five patients with genetic mutations in known CMS genes from 35 families were identified. Mutations in RAPSN were identified in 13 kinships in Israel. The most common mutation was c.-38A>G detected in 8 patients of Iranian and/or Iraqi Jewish origin. Four different recessive mutations in COLQ were identified in 11 kinships, 10 of which were of Muslim-Arab descent. Mutations in CHRNE were identified in 7 kinships. Less commonly detected mutations were in CHRND, CHAT, GFPT1 and DOK7. In conclusion, mutations in RAPSN and COLQ are the most common causes of CMS in our cohort. Specific mutations in COLQ, RAPSN, and CHRNE occur in specific ethnic populations and should be taken into account when the diagnosis of a CMS is suspected.